Adaptive Biotechnologies (ADPT) Tops Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $21.40 +2.10%
EPS Growth %: +17.6%
Financial Fact:
Net income (loss): -65.15M
Today's EPS Names:
DTGI, OCCI, MAYS, More
EPS Growth %: +17.6%
Financial Fact:
Net income (loss): -65.15M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q2 EPS of ($0.35), $0.07 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $38.5 million versus the consensus estimate of $31.26 million.
GUIDANCE:
Adaptive Biotechnologies sees FY2021 revenue of $148-155 million, versus the consensus of $150.2 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
- AeroVironment posts record quarterly revenue, issues FY2027 outlook
- Methanex to idle Trinidad Titan plant after gas contract talks fail
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
